MORGAN ALLEN: Open Payments
NPI 1881157667 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 61 payments from 15 companies in 2025. Trend: 2023 $162 · 2024 $300 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $176 |
| Novo Nordisk Inc | 12 | $164 |
| Bayer Healthcare Pharmaceuticals Inc. | 20 | $149 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $81 |
| Lundbeck LLC | 3 | $67 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Tactile Systems Technology Inc | 1 | $20 |
| PFIZER INC. | 1 | $19 |
Products named: Kerendia, AIRSUPRA, Ozempic, XIFAXAN, FARXIGA, VYEPTI, GARDASIL 9, CAPLYTA.
Industry payments across SC — which companies pay providers there.
